Hydromorphone HCl injection 1mg/mL recalled due to overdose risk
Prefilled glass cartridges of hydromorphone HCI injection 1 mg/mL manufactured by Hospira may contain more than the labeled 1 mL fill volume.
Prefilled glass cartridges of hydromorphone HCI injection 1 mg/mL manufactured by Hospira may contain more than the labeled 1 mL fill volume.
American Regent has issued a nationwide voluntary recall of epinephrine injection, 1:1000, 1mL ampules after concerns that visible particulates in some ampules could cause adverse events if administered intravenously.
The FDA has approved the oral contraceptive, Natazia, to treat women with heavy menstrual bleeding that is not caused by a diagnosed condition of the uterus.
Surfaxin (lucinactant) is indicated for the prevention of respiratory distress syndrome, a breathing disorder that affects premature infants.
Drug interactions between statins and certain protease inhibitors for HIV or hepatitis C can increase the risk for myopathy, including rhabdomyolysis.
Sleeping pill use was associated with a three- to five-fold higher mortality risk compared to nonuse, even among patients taking relatively few pills a year.
Glenmark Generics Inc. has issued a voluntary nationwide recall of seven lots of the oral contraceptives norgestimate and ethinyl estradiol, after consumers reported that the tablets in some packages were in reverse order.
American Regent has issued a nationwide voluntary recall of Phenylephrine HCl Injection, USP, 1% (10mg/mL), 5mL vials.
McNeil Consumer Healthcare is voluntarily recalling seven lots of Infants’ Tylenol Oral Suspension, 1oz Grape, distributed nationwide in the U.S.
The FDA is warning health care professionals about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States.